baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out PGR/ DE000GG4YQE5 /

20/05/2024 21:38:17	Chg.-	Bid10:00:03	Ask10:00:03	Underlying	Strike price	Expiration date	Option type
1.35EUR	-	1.39 Bid Size: 3,000	- Ask Size: -	Progressive Corporat...	193.7291 USD	31/12/2078	Call

GlobeNewswire 20/05 Aerami Therapeutics Presents New Lung Deposition Modeling Data For AER-901 in Pulmonary Hypertension...

GlobeNewswire 20/05 Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...

TeleTrader 20/05 Yellen says US against tax on billionaires

GlobeNewswire 20/05 APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...

GlobeNewswire 20/05 Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...

GlobeNewswire 20/05 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...

GlobeNewswire 16/05 BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...

GlobeNewswire 15/05 Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...

TeleTrader 15/05 Slovakian opposition denies connection to Fico's attack

GlobeNewswire 15/05 Progressive Reports April 2024 Results

GlobeNewswire 14/05 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...

GlobeNewswire 13/05 Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...

GlobeNewswire 13/05 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...

GlobeNewswire 13/05 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...

GlobeNewswire 09/05 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...

GlobeNewswire 09/05 Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...

GlobeNewswire 08/05 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...

GlobeNewswire 07/05 MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...

GlobeNewswire 06/05 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...

GlobeNewswire 04/05 The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats

GlobeNewswire 02/05 PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...

GlobeNewswire 01/05 Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...

GlobeNewswire 01/05 Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...

GlobeNewswire 01/05 Opthea Announces Upcoming Presentations at the Retina World Congress 2024

GlobeNewswire 01/05 Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...

Goldman Sachs Knock-Out PGR/ DE000GG4YQE5 /

If you wish to receive reply to your feedback, please provide your email address.